The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.
  • The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen boost their profits while “artificially” inflating costs for patients.
  • The suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s Express Scripts, and their affiliated group purchasing organizations.
  • The FTC may also recommend suing insulin manufacturers Eli Lilly, Sanofi and Novo Nordisk in the future.
  • Jackcooper@lemmy.world
    1·
    2 months ago

    Independent pharmacist here

    We’ve lost over 9 pharmacies a day in 2024 because of these guys who do everything they can to steer you to their mail order pharmacies.

    They’re absolutely killing us and killing access. Please, do not use mail order.